Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 21)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A ABII: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Standard & Poor's Quantitative Report N/A Abraxis BioScience 6 $25 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ABII 13 $25 View Abstract
8-Feb-10 PriceTarget Research, Inc. N/A Abraxis Bioscience has a current Overall Rating of D (Negative). 7 $25 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ABII , CELG , ENZN , KNDL , LIFE , MATK , ONTY , VRTX -- DRUGS 3 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ABRAXIS BIO -- ABII 1 $4 View Abstract
2-Feb-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Abraxis Bio New (ABII) 8 $50 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ABRAXIS BIOSCIENCE INC 5 $25 View Abstract
Next 11

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
12-Jan-10 Thomson StreetEvents N/A ABII - Event Transcript of Abraxis BioScience, Inc. conference call, Jan. 12, 2010 / 4:00pm ET 6 $75 View Abstract

Independent Reports (Showing 1 to 10 of 20)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A ABII: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Standard & Poor's Quantitative Report N/A Abraxis BioScience 6 $25 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ABII 13 $25 View Abstract
8-Feb-10 PriceTarget Research, Inc. N/A Abraxis Bioscience has a current Overall Rating of D (Negative). 7 $25 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ABII , CELG , ENZN , KNDL , LIFE , MATK , ONTY , VRTX -- DRUGS 3 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ABRAXIS BIO -- ABII 1 $4 View Abstract
2-Feb-10 Wall Street Transcript ,The The Wall St Transcript MANAGEMENT TURNOVER REPORT - Abraxis Bio New (ABII) 8 $50 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ABRAXIS BIOSCIENCE INC 5 $25 View Abstract
Next 10

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.